Precipitin system detected in sera from patients with non-A, non-B hepatitis
✍ Scribed by Dr. Jay H. Hoofnagle
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 331 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A precipitin system detected by immunodiffusion was identified using sera from patients with non‐A, non‐B hepatitis. This system resembled those described by other authors as serological tests for non‐A, non‐B antigens and antibodies. However, testing of sera from a large number of patients with acute and chronic liver diseases revealed that this precipitin system was not specific for non‐A, non‐B hepatitis. Further characterization of the precipitin system demonstrated that it did not represent a true antigen‐antibody reaction. Precipitin lines detected by immunodiffusion during the course of acute and chronic non‐A, non‐B hepatitis may not represent reactions specific for this disease.
📜 SIMILAR VOLUMES
## Abstract Many cases of acute hepatitis remain undiagnosed and the hepatitis E virus (HEV) is emerging in industrialized countries. The aim of this study was to assess the role HEV as causative agent in acute non‐A, non‐B, and non‐C hepatitis patients in Hungary. 10.5% of the 264 acute non‐A, non
## Abstract A group of patients all regularly receiving blood products for a congenital bleeding disorder were investigated for evidence of past infection with hepatitis A and B, and compared with a control group. There was a significantly higher percentage of the test group who had markers of infe
## Abstract In seven patients post‐transfusion hepatitis (PTH) was due to non‐A, non‐B virus(es) (38.9% of all PTH, while 61.1% were due to hepatitis B virus (HBV). No clinical or biochemical differences were observed in non‐A, non‐B PTH when compared with PTH due to HBV, while incubation period wa
## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCV‐RNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic non‐A, non‐B hepatitis (NANBH). Prior to therapy, serum HCV‐RNA w
Two chimpanzees with persistent non-A, non-B (NANB) hepatitis were superinfected with marmoset-passaged MS-1 HAV. Two control chimpanzees were also infected with marmoset-passaged HAV. Neither animal with persistent NANB hepatitis developed elevated alanine aminotransferase (ALT) activity, whereas b